India agrees to sell HCQ tablets to Malaysia to fight Covid-19: Report

Malaysia had asked for more than one million hydroxychloroquine tablets from India, said sources

India has agreed to sell hydroxychloroquine tablets to Malaysia for use in the treatment of Covid-19 patients, a Malaysian minister told Reuters on Wednesday, with New Delhi partially lifting its bar on exports of the anti-malarial drug.

India is the world’s largest producer of hydroxychloroquine, sales of which have soared across the world including in the United States, especially after President Donald Trump touted it as a potential weapon against Covid-19, the disease caused by the novel coronavirus.

New Delhi had last month put a hold on exports of hydroxychloroquine to secure supplies for itself, before agreeing this month to supply it